183 related articles for article (PubMed ID: 31926883)
21. Antibiotics versus control for toxoplasma retinochoroiditis.
Gilbert RE; See SE; Jones LV; Stanford MS
Cochrane Database Syst Rev; 2002; (1):CD002218. PubMed ID: 11869630
[TBL] [Abstract][Full Text] [Related]
22. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.
Maki DG; Fox BC; Kuntz J; Sollinger HW; Belzer FO
J Lab Clin Med; 1992 Jan; 119(1):11-24. PubMed ID: 1727903
[TBL] [Abstract][Full Text] [Related]
23. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis.
Holland GN; Crespi CM; ten Dam-van Loon N; Charonis AC; Yu F; Bosch-Driessen LH; Rothova A
Am J Ophthalmol; 2008 Jun; 145(6):1007-1013. PubMed ID: 18343351
[TBL] [Abstract][Full Text] [Related]
24. Role of IgG avidity in eyes with active Toxoplasma retinochoroiditis.
Lakhmawar P; Kelgaonkar A; Patel A; Khalsa A; Basu S
Indian J Ophthalmol; 2024 Jul; 72(Suppl 4):S601-S605. PubMed ID: 38324620
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Toxoplasmic Retinochoroiditis in an Australian Adult Population: A Community-Based Study.
Ferreira LB; Furtado JM; Charng J; Franchina M; Matthews JM; Molan AAL; Hunter M; Mackey DA; Smith JR
Ophthalmol Retina; 2022 Oct; 6(10):963-968. PubMed ID: 35568370
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.
DiRienzo AG; van Der Horst C; Finkelstein DM; Frame P; Bozzette SA; Tashima KT
AIDS Res Hum Retroviruses; 2002 Jan; 18(2):89-94. PubMed ID: 11839141
[TBL] [Abstract][Full Text] [Related]
27. Failure of systemic oral doxycycline in preventing ocular toxoplasmic retinochoroiditis in French military personnel.
Saad S; Delbarre M; Saad R; Berguiga M; Benisty D; Marechal M; Adam T; Froussart F
J R Army Med Corps; 2018 May; 164(2):122-123. PubMed ID: 29317472
[TBL] [Abstract][Full Text] [Related]
28. Clinical pattern of toxoplasmic retinochoroiditis in a Spanish referral center.
Rey A; Llorenç V; Pelegrín L; Mesquida M; Molins B; Rios J; Arévalo JF; Adán A
Ophthalmologica; 2013; 229(3):173-8. PubMed ID: 23548496
[TBL] [Abstract][Full Text] [Related]
29. Scleritis associated with toxoplasmic retinochoroiditis.
Rudich DS; Bhatnagar P
Arch Ophthalmol; 2012 May; 130(5):659-60. PubMed ID: 22652859
[No Abstract] [Full Text] [Related]
30. The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.
Borkowski PK; Brydak-Godowska J; Basiak W; Świtaj K; Żarnowska-Prymek H; Olszyńska-Krowicka M; Kajfasz P; Rabczenko D
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004892. PubMed ID: 27542116
[TBL] [Abstract][Full Text] [Related]
31. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.
Markowitz N; Quinn EL; Saravolatz LD
Ann Intern Med; 1992 Sep; 117(5):390-8. PubMed ID: 1503330
[TBL] [Abstract][Full Text] [Related]
32. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
Peacock JE; Greven CM; Cruz JM; Hurd DD
Bone Marrow Transplant; 1995 Jun; 15(6):983-7. PubMed ID: 7581102
[TBL] [Abstract][Full Text] [Related]
33. Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.
Vishnevskia-Dai V; Achiron A; Buhbut O; Berar OV; Musika AA; Elyashiv SM; Hecht I
Int Ophthalmol; 2020 Apr; 40(4):811-821. PubMed ID: 31792847
[TBL] [Abstract][Full Text] [Related]
34. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
Gribble MJ; Puterman ML
Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.
Bu LN; Chen HL; Chang CJ; Ni YH; Hsu HY; Lai HS; Hsu WM; Chang MH
J Pediatr Surg; 2003 Apr; 38(4):590-3. PubMed ID: 12677572
[TBL] [Abstract][Full Text] [Related]
36. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.
Opremcak EM; Scales DK; Sharpe MR
Ophthalmology; 1992 Jun; 99(6):920-5. PubMed ID: 1630782
[TBL] [Abstract][Full Text] [Related]
37. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.
Holland GN
Am J Ophthalmol; 2004 Jan; 137(1):1-17. PubMed ID: 14700638
[TBL] [Abstract][Full Text] [Related]
38. Diffuse toxoplasmic retinochoroiditis as the initial manifestation of acquired immunodeficiency syndrome.
Lee YF; Chen SJ; Chung YM; Liu JH; Wong WW
J Formos Med Assoc; 2000 Mar; 99(3):219-23. PubMed ID: 10820954
[TBL] [Abstract][Full Text] [Related]
39. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
Zhang Y; Lin X; Lu F
Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
[TBL] [Abstract][Full Text] [Related]
40. Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.
Iravani A
Antimicrob Agents Chemother; 1991 Sep; 35(9):1777-81. PubMed ID: 1952847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
